MAPT and Alzheimer disease: In addition, studies have shown that glutamate has also been linked to the pathophysiology of Alzheimer’s disease (AD), which is characterized by the aggregation of Aβ and tau in the brain that damage learning and memory and prevent synaptic plasticity in neurons (Conway, 2020).